Risk of osteoporosis in patients with chronic inflammatory neuropathy- a population-based cohort study

Seung Woo Kim, Eun Hwa Kim, Jinae Lee, Young Chul Choi, Seung Min Kim, Ha Young Shin

Research output: Contribution to journalArticle

Abstract

The risk of osteoporosis in patients with chronic inflammatory neuropathy (CIN) has not been evaluated in detail. We conducted a population-based case-control study nested in a retrospective cohort to analyze osteoporosis risk among patients with CIN using a nationwide database. Patients with CIN based on the Korean Classification of Disease diagnostic code were included and were matched to controls. A Cox proportional hazards regression model was used to evaluate the effect of CIN on osteoporosis. After propensity score matching, 585 CIN patients and 585 controls were selected. Patients with CIN had an increased osteoporosis risk (hazard ratio [HR] = 2.293, 95% confidence interval [CI] 1.460–3.601) compared with controls. The osteoporosis risk was higher among male patients with CIN than among male controls (HR = 5.404, 95% CI 2.252–12.969), while there were no significant differences among women. Among the CIN patients, the average daily dose of corticosteroids was higher in those who developed osteoporosis (19.6 mg [10.8–49.3]) than those who did not (16.2 mg [7.2–29.1], p = 0.001). The osteoporosis risk among CIN patients is higher than among controls. High risk of osteoporosis in male patients may indicate that osteoporosis in CIN patients results from the disease itself or related treatments.

Original languageEnglish
Article number9131
JournalScientific reports
Volume9
Issue number1
DOIs
Publication statusPublished - 2019 Dec 1

Fingerprint

Osteoporosis
Cohort Studies
Population
Confidence Intervals
Safety Management
Propensity Score
Proportional Hazards Models
Case-Control Studies
Adrenal Cortex Hormones
Odds Ratio
Databases

All Science Journal Classification (ASJC) codes

  • General

Cite this

Kim, Seung Woo ; Kim, Eun Hwa ; Lee, Jinae ; Choi, Young Chul ; Kim, Seung Min ; Shin, Ha Young. / Risk of osteoporosis in patients with chronic inflammatory neuropathy- a population-based cohort study. In: Scientific reports. 2019 ; Vol. 9, No. 1.
@article{b2d9a4c23b6343758e3821c0ec8ac1dd,
title = "Risk of osteoporosis in patients with chronic inflammatory neuropathy- a population-based cohort study",
abstract = "The risk of osteoporosis in patients with chronic inflammatory neuropathy (CIN) has not been evaluated in detail. We conducted a population-based case-control study nested in a retrospective cohort to analyze osteoporosis risk among patients with CIN using a nationwide database. Patients with CIN based on the Korean Classification of Disease diagnostic code were included and were matched to controls. A Cox proportional hazards regression model was used to evaluate the effect of CIN on osteoporosis. After propensity score matching, 585 CIN patients and 585 controls were selected. Patients with CIN had an increased osteoporosis risk (hazard ratio [HR] = 2.293, 95{\%} confidence interval [CI] 1.460–3.601) compared with controls. The osteoporosis risk was higher among male patients with CIN than among male controls (HR = 5.404, 95{\%} CI 2.252–12.969), while there were no significant differences among women. Among the CIN patients, the average daily dose of corticosteroids was higher in those who developed osteoporosis (19.6 mg [10.8–49.3]) than those who did not (16.2 mg [7.2–29.1], p = 0.001). The osteoporosis risk among CIN patients is higher than among controls. High risk of osteoporosis in male patients may indicate that osteoporosis in CIN patients results from the disease itself or related treatments.",
author = "Kim, {Seung Woo} and Kim, {Eun Hwa} and Jinae Lee and Choi, {Young Chul} and Kim, {Seung Min} and Shin, {Ha Young}",
year = "2019",
month = "12",
day = "1",
doi = "10.1038/s41598-019-45591-4",
language = "English",
volume = "9",
journal = "Scientific Reports",
issn = "2045-2322",
publisher = "Nature Publishing Group",
number = "1",

}

Risk of osteoporosis in patients with chronic inflammatory neuropathy- a population-based cohort study. / Kim, Seung Woo; Kim, Eun Hwa; Lee, Jinae; Choi, Young Chul; Kim, Seung Min; Shin, Ha Young.

In: Scientific reports, Vol. 9, No. 1, 9131, 01.12.2019.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Risk of osteoporosis in patients with chronic inflammatory neuropathy- a population-based cohort study

AU - Kim, Seung Woo

AU - Kim, Eun Hwa

AU - Lee, Jinae

AU - Choi, Young Chul

AU - Kim, Seung Min

AU - Shin, Ha Young

PY - 2019/12/1

Y1 - 2019/12/1

N2 - The risk of osteoporosis in patients with chronic inflammatory neuropathy (CIN) has not been evaluated in detail. We conducted a population-based case-control study nested in a retrospective cohort to analyze osteoporosis risk among patients with CIN using a nationwide database. Patients with CIN based on the Korean Classification of Disease diagnostic code were included and were matched to controls. A Cox proportional hazards regression model was used to evaluate the effect of CIN on osteoporosis. After propensity score matching, 585 CIN patients and 585 controls were selected. Patients with CIN had an increased osteoporosis risk (hazard ratio [HR] = 2.293, 95% confidence interval [CI] 1.460–3.601) compared with controls. The osteoporosis risk was higher among male patients with CIN than among male controls (HR = 5.404, 95% CI 2.252–12.969), while there were no significant differences among women. Among the CIN patients, the average daily dose of corticosteroids was higher in those who developed osteoporosis (19.6 mg [10.8–49.3]) than those who did not (16.2 mg [7.2–29.1], p = 0.001). The osteoporosis risk among CIN patients is higher than among controls. High risk of osteoporosis in male patients may indicate that osteoporosis in CIN patients results from the disease itself or related treatments.

AB - The risk of osteoporosis in patients with chronic inflammatory neuropathy (CIN) has not been evaluated in detail. We conducted a population-based case-control study nested in a retrospective cohort to analyze osteoporosis risk among patients with CIN using a nationwide database. Patients with CIN based on the Korean Classification of Disease diagnostic code were included and were matched to controls. A Cox proportional hazards regression model was used to evaluate the effect of CIN on osteoporosis. After propensity score matching, 585 CIN patients and 585 controls were selected. Patients with CIN had an increased osteoporosis risk (hazard ratio [HR] = 2.293, 95% confidence interval [CI] 1.460–3.601) compared with controls. The osteoporosis risk was higher among male patients with CIN than among male controls (HR = 5.404, 95% CI 2.252–12.969), while there were no significant differences among women. Among the CIN patients, the average daily dose of corticosteroids was higher in those who developed osteoporosis (19.6 mg [10.8–49.3]) than those who did not (16.2 mg [7.2–29.1], p = 0.001). The osteoporosis risk among CIN patients is higher than among controls. High risk of osteoporosis in male patients may indicate that osteoporosis in CIN patients results from the disease itself or related treatments.

UR - http://www.scopus.com/inward/record.url?scp=85067859220&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85067859220&partnerID=8YFLogxK

U2 - 10.1038/s41598-019-45591-4

DO - 10.1038/s41598-019-45591-4

M3 - Article

C2 - 31235735

AN - SCOPUS:85067859220

VL - 9

JO - Scientific Reports

JF - Scientific Reports

SN - 2045-2322

IS - 1

M1 - 9131

ER -